| FDA Panel: Approve Rivaroxaban for Stroke Prevention - Internal Medicine News Digital Network |
|
|
Internal Medicine News Digital Network The Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee advisory panel on Sept. 8 voted 9-2, with 1 abstention, that the anticoagulant rivaroxaban is effective for prevention of stroke in nonvalvular atrial fibrillation. ... Bayer Confident in Results of ROCKET AF Study to Be Reviewed by the FDA |